| Summarized financial information for CCE |
The following table provides summarized financial information for CCE for the nine months ended October 1, 2010 (in millions):
|
|
|
|
|
|
Nine Months Ended |
|
|
October 1, 2010 |
|
Net operating revenues |
$ |
16,464 |
|
Cost of goods sold |
10,028 |
|
Gross profit |
$ |
6,436 |
|
Operating income (loss) |
$ |
1,369 |
|
Net income (loss) |
$ |
677 |
|
|
| Summary of significant transactions with CCE |
The following table provides a summary of our significant transactions with CCE for the nine months ended October 1, 2010 (in millions):
|
|
|
|
|
|
Nine Months Ended |
|
|
October 1, 2010 |
|
Concentrate, syrup and finished product sales to CCE |
$ |
4,737 |
|
Syrup and finished product purchases from CCE |
263 |
|
CCE purchases of sweeteners through our Company |
251 |
|
Marketing payments made by us directly to CCE |
314 |
|
Marketing payments made to third parties on behalf of CCE |
106 |
|
Local media and marketing program reimbursements from CCE |
268 |
|
Payments made to CCE for dispensing equipment repair services |
64 |
|
Other payments — net |
19 |
|
|
| Summarized financial information for equity method investees, excluding CCE |
A summary of financial information for our equity method investees in the aggregate, other than CCE, is as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
2012 |
|
|
2011 |
|
|
2010 |
|
Net operating revenues |
$ |
47,087 |
|
|
$ |
42,472 |
|
|
$ |
38,663 |
|
Cost of goods sold |
28,821 |
|
|
26,271 |
|
|
23,053 |
|
Gross profit |
$ |
18,266 |
|
|
$ |
16,201 |
|
|
$ |
15,610 |
|
Operating income |
$ |
4,605 |
|
|
$ |
4,181 |
|
|
$ |
4,134 |
|
Consolidated net income |
$ |
2,993 |
|
|
$ |
2,237 |
|
|
$ |
2,659 |
|
Less: Net income attributable to noncontrolling interests |
89 |
|
|
99 |
|
|
89 |
|
Net income attributable to common shareowners |
$ |
2,904 |
|
|
$ |
2,138 |
|
|
$ |
2,570 |
|
|
|
|
|
|
|
|
|
|
December 31, |
2012 |
|
|
2011 |
|
Current assets |
$ |
16,054 |
|
|
$ |
13,960 |
|
Noncurrent assets |
32,687 |
|
|
27,152 |
|
Total assets |
$ |
48,741 |
|
|
$ |
41,112 |
|
Current liabilities |
$ |
12,004 |
|
|
$ |
10,545 |
|
Noncurrent liabilities |
12,272 |
|
|
11,646 |
|
Total liabilities |
$ |
24,276 |
|
|
$ |
22,191 |
|
Equity attributable to shareowners of investees |
$ |
23,827 |
|
|
$ |
18,392 |
|
Equity attributable to noncontrolling interests |
638 |
|
|
529 |
|
Total equity |
$ |
24,465 |
|
|
$ |
18,921 |
|
Company equity investment |
$ |
9,216 |
|
|
$ |
7,233 |
|
|